Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Press Release

Dr. Adam Friedman joins Vial's Dermatology CRO

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board

San Francisco, CA. November 29, 2022 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Adam Friedman, MD, to their Scientific Advisory Board. Dr. Friedman will advise Vial on enhancing its Dermatology CRO product and services. “We are thrilled to welcome Dr. Friedman to our SAB. We are confident he will contribute relevant and informed counsel to …

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board Read More »

Dr. Marc Hoffmann joins Vials Oncology SAB

Vial Announces the Addition of Dr. Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board

San Francisco, CA. November 27, 2022 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Marc Hoffmann, MD to Vial’s Scientific Advisory Board. Dr. Hoffmann will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Oncology CRO products and services. “Vial’s vision is to empower scientists to cure all human …

Vial Announces the Addition of Dr. Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board Read More »

Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network

San Francisco, CA. November 21, 2022 — Vial has added NEXT Oncology to their Preferred Site Network. Founded by renowned oncologist Dr. Anthony W. Tolcher, NEXT Oncology is a global network of Phase I cancer research clinics dedicated to providing patients access to the latest treatments for advanced cancers. Headquartered in San Antonio, Texas, NEXT Oncology has expanded …

Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network Read More »

Vial welcomes Dr. Rajesh Pahwa to their Neurology CRO.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

San Francisco, CA. November 16, 2022 — Vial welcomes Rajesh Pahwa, MBBS, MD, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson’s and Movement Disorder Division and a professor of neurology at the University of Kansas Medical Center, which has been designated as one of 33 Centers …

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board Read More »

Dr. Joseph Jankovic of Baylor College of Medicine to their Neurology CRO Advisory Board

Vial Welcomes New Addition, Dr. Joseph Jankovic of Baylor College of Medicine to their Neurology CRO Advisory Board

San Francisco, CA. November 9, 2022 — Vial welcomes Dr. Joseph Jankovic as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Jankovic is a Professor of Neurology, a Distinguished Chair in Movement Disorders, and the Director of the Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) at the Baylor College of Medicine. Dr. …

Vial Welcomes New Addition, Dr. Joseph Jankovic of Baylor College of Medicine to their Neurology CRO Advisory Board Read More »

Dr. Robert Hauser becomes scientific advisor to Vial's Neurology CRO.

Robert A. Hauser, MD, MBA, of the Parkinson’s Disease and Movement Disorders Center, University of South Florida, joins Vial’s Neurology CRO Scientific Advisory Board.

San Francisco, CA. November 7, 2022 — Vial welcomes Robert A. Hauser, MD, MBA, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Hauser is the Director of the Parkinson’s Disease and Movement Disorder Center and a Professor of Neurology, at the University of South Florida. Vial is a tech-enabled CRO providing next-generation clinical …

Robert A. Hauser, MD, MBA, of the Parkinson’s Disease and Movement Disorders Center, University of South Florida, joins Vial’s Neurology CRO Scientific Advisory Board. Read More »

Dr. Nathan Pennell

Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial’s Oncology CRO Advisory Board

San Francisco, CA. November 1 2022 — Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute has joined Vial’s Oncology CRO Advisory Board. Dr. Pennell will advise Vial on enhancing its Oncology CRO product and services. Nathan Pennell, MD, Ph.D., FASCO, is a Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the …

Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial’s Oncology CRO Advisory Board Read More »